The available drugs for neurodegenerative conditions like multiple sclerosis (MS) can only treat symptoms, or at best slow the disease’s march forward. But recent research has uncovered a new approach that could potentially address what causes nerves to break down in the first place. Startup Disarm Therapeutics aims to turn that research into new drugs […]